España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lexeo Therapeutics
LXEO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$8.05
0.27
3.47%
Pre-Market: 6:09 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
Lexeo Therapeutics (LXEO) Forecast
News
Earnings
Lexeo Therapeutics (LXEO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lexeo Therapeutics (NASDAQ:LXEO) Stock
Lexeo Therapeutics Stock (NASDAQ: LXEO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
HC Wainwright & Co. Maintains Buy on Lexeo Th...
Benzinga Newsdesk
Wednesday, November 13, 2024
Chardan Capital Maintains Buy on Lexeo Therap...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Lexeo Therapeutics shares are trading higher....
Benzinga Newsdesk
Leerink Partners Maintains Outperform on Lexe...
Benzinga Newsdesk
Thursday, October 31, 2024
HC Wainwright & Co. Reiterates Buy on Lexeo T...
Benzinga Newsdesk
Wednesday, October 30, 2024
Chardan Capital Maintains Buy on Lexeo Therap...
Benzinga Newsdesk
Lexeo Therapeutics shares are trading lower. ...
Benzinga Newsdesk
Lexeo Therapeutics Announced Interim Results ...
Benzinga Newsdesk
Friday, October 25, 2024
Chardan Capital Maintains Buy on Lexeo Therap...
Benzinga Newsdesk
Tuesday, October 22, 2024
Lexeo Therapeutics Says Interim Data From Ong...
Benzinga Newsdesk
Wednesday, August 14, 2024
Chardan Capital Maintains Buy on Lexeo Therap...
Benzinga Newsdesk
Tuesday, August 13, 2024
HC Wainwright & Co. Maintains Buy on Lexeo Th...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Lexeo Th...
Benzinga Newsdesk
Monday, August 12, 2024
Lexeo Therapeutics Q2 2024 GAAP EPS $(0.64) B...
Benzinga Newsdesk
Wednesday, July 17, 2024
Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data
Zacks
Tuesday, July 16, 2024
HC Wainwright & Co. Reiterates Buy on Lexeo T...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Lexeo Therap...
Benzinga Newsdesk
Monday, July 15, 2024
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
Avi Kapoor
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
Avi Kapoor
Lezeo Therapeutics shares are trading lower. ...
Benzinga Newsdesk
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
Avi Kapoor
Lexeo Therapeutics Report Interim Data Of LX2...
Benzinga Newsdesk
Thursday, July 11, 2024
Lexeo Therapeutics shares are trading higher ...
Benzinga Newsdesk
Lexeo Therapeutics To Host Investor Webcast T...
Benzinga Newsdesk
Thursday, June 13, 2024
Baird Initiates Coverage On Lexeo Therapeutic...
Benzinga Newsdesk
Thursday, June 06, 2024
HC Wainwright & Co. Initiates Coverage On Lex...
Benzinga Newsdesk
Monday, April 22, 2024
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Lexeo Therapeutics Announces In-License Agree...
Benzinga Newsdesk
Tuesday, April 16, 2024
Lexeo Therapeutics shares are trading higher ...
Benzinga Newsdesk
Lexeo Therapeutics Granted FDA Fast Track Des...
Benzinga Newsdesk
Tuesday, March 12, 2024
RBC Capital Maintains Outperform Rating for Lexeo Therapeutics: Here's What You Need To Know
Benzinga Insights
RBC Capital Maintains Outperform on Lexeo The...
Benzinga Newsdesk
Monday, March 11, 2024
Lexeo Therapeutics shares are trading lower a...
Benzinga Newsdesk
LEXO shares are trading higher after the comp...
Benzinga Newsdesk
Lexeo Therapeutics Q4 EPS $(0.86) Up From $(8.86) YoY
Happy Mohamed
Lexeo Therapeutics Reveals Oversubscribed $95...
Benzinga Newsdesk
Wednesday, March 06, 2024
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Thursday, January 18, 2024
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Tuesday, December 26, 2023
Marathon Digital, Canaan, CleanSpark And Other Big Stocks Moving Lower On Tuesday
Avi Kapoor
Monday, December 18, 2023
Lexeo Therapeutics Says FDA Granted Fast Trac...
Benzinga Newsdesk
Monday, December 11, 2023
Lexeo Therapeutics Q3 EPS $(12.36) Down From ...
Benzinga Newsdesk
Friday, December 01, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, November 28, 2023
Chardan Capital Initiates Coverage On Lexeo T...
Benzinga Newsdesk
Leerink Partners Initiates Coverage On Lexeo ...
Benzinga Newsdesk
RBC Capital Initiates Coverage On Lexeo Thera...
Benzinga Newsdesk
Stifel Initiates Coverage On Lexeo Therapeuti...
Benzinga Newsdesk
JP Morgan Initiates Coverage On Lexeo Therape...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch